Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals-Reference-Cited by-同舟云学术

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

Published:2018 Issue:2 Volume:7 Page:190-204
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Finkelmeier Fabian,Dultz Georg,Peiffer Kai-Henrik,Kronenberger Bernd,Krauss Franziska,Zeuzem Stefan,Sarrazin Christoph,Vermehren Johannes,Waidmann Oliver

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Reference47 articles.

1. Lavanchy D: Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107–115.

2. Polaris Observatory HCV Collaborators S, Zeuzem S, Manns M, et al: Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017; 2: 161–176.

3. Thein HH, Yi Q, Dore GJ, Krahn MD: Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008; 48: 418–431.

4. Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002; 36(suppl 1):S35–S46.

5. Poynard T, Mathurin P, Lai CL, et al: A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003; 38: 257–265.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal;Hepatoma Research;2023

2. Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C;International Journal of Molecular Sciences;2022-12-07

3. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches;World Journal of Gastroenterology;2022-06-14

4. Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis;Clinical Gastroenterology and Hepatology;2022-05

5. Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate;World Journal of Clinical Cases;2022-02-26